CCL20 and neoplasm: NDV-MIP3α and control NDV-WT were injected into the B16 tumor masses in C57Bl/6 mice and CT26 in BALB/c mice, when the tumor masses were palpable at about day 5 after tumor cells were injected subcutaneously.